Megan McAuliffe

690 total citations
11 papers, 532 citations indexed

About

Megan McAuliffe is a scholar working on Genetics, Oncology and Epidemiology. According to data from OpenAlex, Megan McAuliffe has authored 11 papers receiving a total of 532 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Genetics, 3 papers in Oncology and 3 papers in Epidemiology. Recurrent topics in Megan McAuliffe's work include Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (3 papers), Microscopic Colitis (3 papers) and Inflammatory Bowel Disease (3 papers). Megan McAuliffe is often cited by papers focused on Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (3 papers), Microscopic Colitis (3 papers) and Inflammatory Bowel Disease (3 papers). Megan McAuliffe collaborates with scholars based in United States, Canada and United Kingdom. Megan McAuliffe's co-authors include Melissa J. Perry, Serap Sankoh, Arpeat Kaviya, Reema Mody, Silvio Danese, Brian G. Feagan, David T. Rubin, Michael Smyth, Edward V. Loftus and Ira Shafran and has published in prestigious journals such as Environmental Health Perspectives, The American Journal of Gastroenterology and Human Reproduction.

In The Last Decade

Megan McAuliffe

11 papers receiving 515 citations

Peers

Megan McAuliffe
Paul Mayor United States
Dariusz Ładoń United Kingdom
Ritva Nissi Finland
N.T. Gorman United Kingdom
Megan McAuliffe
Citations per year, relative to Megan McAuliffe Megan McAuliffe (= 1×) peers Jarosław Leszczyszyn

Countries citing papers authored by Megan McAuliffe

Since Specialization
Citations

This map shows the geographic impact of Megan McAuliffe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Megan McAuliffe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Megan McAuliffe more than expected).

Fields of papers citing papers by Megan McAuliffe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Megan McAuliffe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Megan McAuliffe. The network helps show where Megan McAuliffe may publish in the future.

Co-authorship network of co-authors of Megan McAuliffe

This figure shows the co-authorship network connecting the top 25 collaborators of Megan McAuliffe. A scholar is included among the top collaborators of Megan McAuliffe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Megan McAuliffe. Megan McAuliffe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Parikh, Asit, Eugene O. Major, Irving H. Fox, et al.. (2018). A Programme for Risk Assessment and Minimisation of Progressive Multifocal Leukoencephalopathy Developed for Vedolizumab Clinical Trials. Drug Safety. 41(8). 807–816. 4 indexed citations
2.
Loftus, Edward V., Jean‐Frédéric Colombel, Brian G. Feagan, et al.. (2016). Long-term Efficacy of Vedolizumab for Ulcerative Colitis. Journal of Crohn s and Colitis. 11(4). jjw177–jjw177. 167 indexed citations
3.
Vermeire, Séverine, Edward V. Loftus, Jean‐Frédéric Colombel, et al.. (2016). Long-term Efficacy of Vedolizumab for Crohn’s Disease. Journal of Crohn s and Colitis. 11(4). jjw176–jjw176. 168 indexed citations
4.
Macalalad, Alexander R., Megan McAuliffe, Hongbo Yang, et al.. (2015). The epidemiology and targeted therapies for relapsed and refractory CD30+ lymphomas. Current Medical Research and Opinion. 31(3). 537–545. 5 indexed citations
5.
McAuliffe, Megan, Stephan Lanes, Timothy Leach, et al.. (2015). Occurrence of adverse events among patients with inflammatory bowel disease in the HealthCore Integrated Research Database. Current Medical Research and Opinion. 31(9). 1655–1664. 32 indexed citations
6.
McAuliffe, Megan, Paige L. Williams, Susan Korrick, et al.. (2014). Human sperm sex chromosome disomy and sperm DNA damage assessed by the neutral comet assay. Human Reproduction. 29(10). 2148–2155. 6 indexed citations
7.
Clifford, David, Megan McAuliffe, Eugene O. Major, et al.. (2013). Risk Assessment and Minimization for Progressive Multifocal Leukoencephalopathy (PML RAMP): A Program to Assess for Potential Early Signs and Symptoms of PML during Clinical Development of Vedolizumab. The American Journal of Gastroenterology. 108. S502–S502. 7 indexed citations
8.
McAuliffe, Megan, et al.. (2012). The association between sperm sex chromosome disomy and semen concentration, motility and morphology. Human Reproduction. 27(10). 2918–2926. 14 indexed citations
9.
McAuliffe, Megan, Paige L. Williams, Susan Korrick, Larisa Altshul, & Melissa J. Perry. (2011). Environmental Exposure to Polychlorinated Biphenyls and p,p ´-DDE and Sperm Sex-Chromosome Disomy. Environmental Health Perspectives. 120(4). 535–540. 42 indexed citations
10.
Perry, Melissa J., Xing Chen, Megan McAuliffe, Arnab Maity, & Glen M. DeLoid. (2011). Semi‐automated scoring of triple‐probe FISH in human sperm: Methods and further validation. Cytometry Part A. 79A(8). 661–666. 18 indexed citations
11.
McAuliffe, Megan & Melissa J. Perry. (2007). Are nanoparticles potential male reproductive toxicants? A literature review. Nanotoxicology. 1(3). 204–210. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026